AI summary · may contain errors
Cellular and molecular imaging is positioned to enable new, personalized risk assessment in coronary artery disease by visualizing inflammatory and other atherosclerosis activity beyond structural burden.
- 3 cites
Moving in European Heart Journal, Journal of the American College of Cardiology, JAMA Cardiology, New England Journal of Medicine, Cardiovascular Research, medRxiv, Nature Reviews Cardiology and The Lancet.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
Cellular and molecular imaging is positioned to enable new, personalized risk assessment in coronary artery disease by visualizing inflammatory and other atherosclerosis activity beyond structural burden.
AI summary · may contain errors
Prophylactic SynFlow 3.0 micro-axial flow pump during non-emergent high-risk PCI in patients with LVEF ≤35% is non-inferior to VA-ECMO for 30-day major adverse events (7.34% vs 11.5%).
AI summary · may contain errors
In 110 933 patient presentations with suspected myocardial infarction, the 0/1 h pathway showed 0·8% vs 1·0% 30-day all-cause death or new type 1 myocardial infarction (pooled OR 0·83, 95% CI 0·45–1·53).
AI summary · may contain errors
Healed atherosclerotic plaques show layered morphology in vivo on optical coherence tomography, and are linked to chronic coronary syndromes in patients.
AI summary · may contain errors
In the DECISION-CTO randomized trial, initial CTO-PCI versus no CTO-PCI produced similar 10-year primary endpoint rates (33.9% vs 37.4%) in 804 patients.
AI summary · may contain errors
In an international randomized trial of 1105 revascularization patients, CCTA-guided PCI was noninferior to IVUS-guided PCI for 12-month target-vessel failure (4.1% vs 4.6%).
AI summary · may contain errors
Quantitative plaque analysis using coronary computed tomography angiography (CCTA) is discussed as a potential screening approach in asymptomatic adults, but current evidence is not yet sufficient to support clinical use for guiding therapy.
AI summary · may contain errors
DeepCORO-CLIP, trained on 203,808 angiographic videos and 28,117 patients’ reports, detects obstructive coronary stenosis (≥70%) with AUROC 0.89 across internal and external testing.
AI summary · may contain errors
No-touch saphenous vein harvesting in primary, nonemergent isolated CABG did not significantly reduce 7-year death, myocardial infarction, or repeat revascularization versus conventional harvesting (19.8% vs 20.4%).
AI summary · may contain errors
In EPIDAURUS, a 1-month DOAC plus potent P2Y12 inhibitor regimen (prasugrel or ticagrelor) in atrial fibrillation plus acute coronary syndrome was linked to higher bleeding rates in 602 enrolled patients.
AI summary · may contain errors
Angiography-derived vessel fractional flow reserve (vFFR)–guided revascularization is noninferior to wire-based pressure FFR for intermediate coronary stenoses at 1 year, with MACE 3.0% vs 4.1%.
AI summary · may contain errors
In 553 Netherlands patients with angina and nonobstructive coronary arteries, continuous thermodilution-derived microvascular resistance reserve did not predict the 3-category composite outcome (log-rank P=.85).
AI summary · may contain errors
In 133 OPTICO-ACS patients, plaque erosion shows clonal expansion and anti-inflammatory memory-skewed CD4+ and CD8+ T cell programs, contrasting with rupture’s naive/pro-inflammatory profile.
AI summary · may contain errors
ARC-HBR criteria identify STEMI patients undergoing primary PCI with substantially higher 12-month risk, but do not show a more favorable effect for upfront aspirin omission.
AI summary · may contain errors
Aspirin withdrawal after PCI shows MI odds ratios linked to DAPT duration, with the MI OR dropping below 1.15 from about 90 days.
Journals this month
Topics moving, week to 17 Nov 2026
By field